We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Immunophenotypic analyses of CD34<sup>+</sup> cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy.
- Authors
Müller, F.; Tjønnfjord, G. E.; Nordøy, I.; Kvale, D.; Mellbye, O. J.; Aukrust, P.; Frøland, S. S.
- Abstract
Abstract Background Because increased bone marrow lymphopoiesis might contribute to immunologic reconstitution during highly-active antiretroviral therapy (HAART), we examined the effect of HAART on CD34+ cell subsets in bone marrow from HIV-infected patients. Materials and Methods In 12 HIV-infected patients, bone marrow and peripheral blood were collected before then 4 and 26 weeks after initiating HAART. Bone marrow in 28 HIV-seronegative controls was also examined. Immunophenotypic analyses of CD34+ cell subsets in bone marrow were performed by flow cytometry. Results Our main findings in bone marrow were: (i) HIV-infected patients had increased proportions of CD34+ cells expressing T- and B-cell markers before initiating HAART; (ii) in contrast, these patients had decreased proportions of CD34 + cells expressing myeloid-associated markers; (iii) although HAART induced an increase in peripheral T-cell counts, the percentage of CD34 + cells expressing T-cell markers tended to decrease during such therapy; (iv) HAART induced a decrease in serum IgG accompanied by a slight decrease in the proportion of CD34 + cells expressing B-cell markers; (v) in contrast, HAART induced a significant increase in peripheral granulocyte counts, accompanied by a slightly increased proportion of CD34 + cells expressing myeloid-associated molecules. Conclusion Our findings are compatible with an HIV-related block in T-cell differentiation, leading to accumulation of T-cell progenitors in bone marrow, and such a block may be removed by HAART.
- Subjects
BONE marrow diseases; RETROVIRUS disease treatment; HIV-positive persons
- Publication
European Journal of Clinical Investigation, 2002, Vol 32, Issue 7, p535
- ISSN
0014-2972
- Publication type
Article
- DOI
10.1046/j.1365-2362.2002.00995.x